Health & Life Sciences

Saudi Arabia 2020 - Health & Life Sciences

The outlook for the health care sector remains positive despite Saudi Arabia facing a number of challenges in terms of increasing capacity to meet rising demand and a higher incidence of non-communicable diseases, as well as the more recent threat of Covid-19. The government’s efforts to restructure the public sector through decentralisation and digitalisation initiatives are increasing efficiency and reducing costs. Meanwhile, ongoing privatisation and efforts to create a more competitive health care environment are improving care and attracting significant investment. The shift towards public-private partnerships and build-operate-transfer contracts is expected to support private sector activity in the decade to come, while the burgeoning health start-up ecosystem is set to contribute to a greater level of digitalisation. This chapter contains an interview with Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority.

Share
Cover of The Report: Saudi Arabia 2020

The Report

This chapter is from the Saudi Arabia 2020 report. Explore other chapters from this report.

Interviews & Viewpoints

Sketch of Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA)
Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA): Interview

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart